Ушбу иш иқтибос қилган ишлар

41 та иш

Иш: Ways to overcome difficulties in diagnosing non-alcoholic fatty liver disease

NAFLD: Mechanisms, Treatments, and Biomarkers
Fatiha Nassir
Шарҳ мақола20224 иқтибос
ABI
Non-coding RNA regulatory networks
Simona Panni, Ruth C. Lovering, Pablo Porras +1
Шарҳ мақола20194 иқтибос
ABI
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair M. Younossi, Quentin M. Anstee, M. Marietti +5
Шарҳ мақола20173 иқтибос
ABI
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella +1
Шарҳ мақола20183 иқтибос
ABI
Unraveling the genetics of fatty liver in obese children: Additive effect of P446L GCKR and I148M PNPLA3 polymorphisms
Luca Valenti, Anna Alisi, Valério Nobili
Бошқа20123 иқтибос
ABI
Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent
Stefano Romeo, Federica Sentinelli, Satya Dash +9
Мақола20093 иқтибос
ABI
Role of the PNPLA3 I148M Polymorphism in Nonalcoholic Fatty Liver Disease and Fibrosis in Korea
Sang Soo Lee, Young-Sang Byoun, Sook‐Hyang Jeong +4
Мақола20143 иқтибос
ABI
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies
Ahmad Al‐Serri, Quentin M. Anstee, Luca Valenti +8
Мақола20113 иқтибос
ABI
Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid Acyltransferase
Manju Kumari, Gabriele Schoiswohl, Chandramohan Chitraju +18
Мақола20123 иқтибос
ABI
Nonalcoholic fatty liver disease: What do we know and what will we have to learn?
Н. И. Волкова, Maria Porksheyan
Шарҳ мақола20173 иқтибос
ABI
NASH in Lean Individuals
Ramy Younes, Elisabetta Bugianesi
Шарҳ мақола20193 иқтибос
ABI
Diagnosis and management of non-alcoholic fatty liver disease
Erica Jennison, Janisha Patel, Eleonora Scorletti +1
Шарҳ мақола20193 иқтибос
ABI
Epidemiology of chronic liver diseases in the USA in the past three decades
Zobair M. Younossi, Maria Stepanova, Youssef Younossi +4
Мақола20193 иқтибос
ABI
Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers
Olfa Khalifa, Khaoula Errafii‬, Nayla S. Al-Akl +1
Шарҳ мақола20203 иқтибос
ABI
MM-associated circular RNA downregulates microRNA-19a through methylation to suppress proliferation of pancreatic adenocarcinoma cells
Xinye Qian, Wenru Zong, Liqing Ma +4
Мақола20223 иқтибос
ABI
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter, Mary E. Rinella
Шарҳ мақола20202 иқтибос
ABI
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
Rohit Loomba, Tanya Wolfson, Brandon Ang +9
Мақола20142 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI